Frankfurt
18.07.25 | 08:03
0,099 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | Vext Science Inc: Vext receives dual-use provisional licence in Ohio | 1 | Stockwatch | ||
| 24.06. | VEXT Science, Inc.: Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield | 233 | Newsfile | Secures a provisional license for sixth Ohio dispensary in Fairfield, with operations expected to begin in Q4 2025, subject to regulatory approvals.Demonstrates Vext's strategic approach to retail... ► Artikel lesen | |
| 16.06. | Vext Science Inc: Vext Science opens fifth dispensary in Ohio | 1 | Stockwatch | ||
| 16.06. | VEXT Science, Inc.: Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market | 265 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 06.06. | Vext Science Inc: Vext Science changes auditor to MNP | 1 | Stockwatch | ||
| 05.06. | VEXT Science, Inc.: Vext Announces Change of Auditor | 472 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 23.05. | Vext Science is a buy, Ventum Capital says | 3 | Cantech Letter | ||
| 21.05. | Vext Science reports Q1 results | 5 | Seeking Alpha | ||
| 21.05. | VEXT Science, Inc.: Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue | 378 | Newsfile | Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio.Q1 2025 operating cash flow reached $3.1 million... ► Artikel lesen | |
| 13.05. | Vext Science Inc: Vext Science to release Q1 2025 results May 21 | 5 | Stockwatch | ||
| 13.05. | VEXT Science, Inc.: Vext to Announce Financial Results for Q1 2025 on May 21, 2025 | 312 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 13, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona... ► Artikel lesen | |
| 04.04. | Vext Science Inc: Vext unit to sell Kentucky cannabis processing licence | 2 | Stockwatch | ||
| 04.04. | VEXT Science, Inc.: Vext Strengthens Balance Sheet and Sharpens Focus on Core Markets with Strategic Sale of Kentucky Medical Processing License | 423 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertically integrated operations... ► Artikel lesen | |
| 03.04. | Vext Science Inc: Vext completes buy of two Ohio dispensaries | 3 | Stockwatch | ||
| 03.04. | VEXT Science, Inc.: Vext Completes Ohio Expansion Transaction, Expanding Ohio Retail Presence to Four Dispensaries | 381 | Newsfile | Vext now operates four retail dispensaries in Ohio's limited license market and remains on track to reach the state license cap of eight (8) total dispensaries, with new locations expected to open... ► Artikel lesen | |
| 01.04. | VEXT Science keeps buy rating at Ventum | 4 | Cantech Letter | ||
| 31.03. | Vext Science reports Q4 results | 3 | Seeking Alpha | ||
| 31.03. | VEXT Science, Inc.: Vext Delivers Solid Q4 Financial Results - Turning Point as Ohio Operations Gain Momentum | 234 | Newsfile | Q4 2024 marked Vext's strongest operating quarter in recent years, with growth across revenue, adjusted EBITDA, and cash flow.Revenue of $10.2 million in Q4 2024 (+13% QoQ), driven by Ohio adult-use... ► Artikel lesen | |
| 19.03. | Vext Science Inc: Vext Science to release 2024 results March 31 | 2 | Stockwatch | ||
| 19.03. | VEXT Science, Inc.: Vext to Announce Financial Results for Q4 and Fiscal 2024 on March 31, 2025 | 424 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,890 | -0,38 % | Stocks in Play: Aurora Cannabis Inc. | ||
| CANOPY GROWTH | 0,952 | -0,10 % | Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 0,531 | -0,60 % | Tilray Brands, Inc.: Breckenridge Distillery Launches Mock One: Bold, Premium Non-Alcoholic Alternatives to Whiskey, Tequila, Gin & Rum - Crafted for Everyone Who Loves a Great Drink | ||
| INNOCAN PHARMA | 0,133 | +1,92 % | Gamechanger: FDA Studie - Innocan Pharma der Gewinner?! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| CRONOS GROUP | 1,733 | +0,46 % | High Tide schließt mit Cronos Group Inc. eine Vereinbarung über Wandelschuldverschreibungen im Wert von 30 Millionen $ ab | CALGARY, AB, und TORONTO, ON, 16. Juli 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das
erfolgreiche, auf den Einzelhandel fokussierte... ► Artikel lesen | |
| SYNBIOTIC | 3,185 | +2,91 % | SYNBIOTIC SE: Update von der mwb-Konferenz: Diversifiziertes Geschäftsmodell gewinnt an Dynamik; mwb research empfiehlt KAUFEN | Auf der mwb research Health Care Conference bekräftigten CEO Daniel Kruse und sein Team den strategischen Fokus von SYNBIOTIC auf ein plattformbasiertes Buy-and-Build-Modell in wachstumsstarken Cannabis-... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| ORGANIGRAM GLOBAL | 1,220 | -3,17 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 02.04.2025 | The following instruments on XETRA do have their first trading 02.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.04.2025
Aktien
1 ROMEDLACNOR6 MedLife S.A.
2 CA29872T2092... ► Artikel lesen | |
| SNDL | 1,399 | +5,90 % | 1CM Inc.: 1CM Receives Court Approval for Arrangement with SNDL Inc | Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM" or the "Company") is pleased to announce that the Ontario Superior Court of Justice (Commercial... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 4,784 | -0,91 % | Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold? | ||
| CRESCO LABS | 0,461 | -2,62 % | Cresco Labs Inc: Cresco Labs to release Q2 results Aug. 7 | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | +33,33 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen |
Das Unternehmen VEXT SCIENCE INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,099 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.